The Cann Group Ltd (ASX: CAN) share price got smoked today on news that a major shareholder and partner sold out of the stock.
Shares in the medicinal cannabis group tanked 7.1% to 39 cents in after lunch trade when the S&P/ASX SMALL ORDINARIES (Index: ^AXSO) and S&P/ASX 200 Index (Index:^AXJO) gained around 0.1% each.
Investors dumped the stock after Aurora Cannabis Inc (TSE: ACB) informed Cann Group that it sold its 11.84% shareholding in the ASX company.
Cann Group share price takes a blow
The sale was done via off-market trades to a small number of undisclosed buyers after the market closed on Friday.
Management tried to appease shareholders by stating that Aurora’s decision to sell down the shares was “consistent with Aurora’s current strategic priorities”.
It also added that Aurora’s exit won’t have an impact on Cann Group’s business plans. Cann Group remains focused on developing a growing and diversified supply base with B2B customers in Australia and overseas.
Off-take partner exits right
But investors aren’t listening. Aurora isn’t only a substantial shareholder, but it’s also a partner as it signed a five-year off-take agreement with Cann Group in March 2019.
Under the agreement, Cann Group will supply good manufacturing practice (GMP) processed dry flower, extracted resin and medicinal cannabis products to Aurora, which is one of the world’s largest cannabis companies.
No commercial details were released then but it’s believed to include a price review mechanism. It also allows for the inclusion of new products that the group develops.
No sugar coating the Cann Group share price fall
It’s interesting that Aurora said the sale of its remaining holdings in Cann Group was inline with its strategic priorities. Back when it struck the off-take agreement with Cann Group, the CAN share price was trading at around $2 a share.
It looks like Aurora decided to bite the bullet and crystalise the loss. That perception won’t help confidence in the Cann Group share price.
But Cann Group isn’t the only stock that’s fallen out of favour with the market. In fact, the ASX medicinal cannabis sector is nursing a big hangover as it comes off a high.
The sector serves as a warning about how dangerous it can be to be buying hype ahead of fundamentals, even though medicinal cannabis is a real industry.
These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)
Motley Fool Australia's Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.
Our team of investors think these 3 dividend stocks should be a 'must consider' for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.
Don't miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.
Returns As of 15th February 2021
The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- This beaten-down ASX sector could soon be turning the corner – April 12, 2021 4:19pm
- Orocobre (ASX:ORE) share price rebounds from broker downgrade – April 12, 2021 12:39pm
- Fears of new supermarket war could hit Coles (ASX:COL) and Woolworths (ASX:WOW) – April 9, 2021 12:44pm